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Worldwide reduction in blindness: making progress? 
Heraclitus believed that everything is in ﬂ ux, that 
change encompasses the natural world and the human 
condition. History buttresses this notion, and the years 
since 1990 are no exception. Between then and now the 
world has witnessed tremendous change: the internet, 
social media, 9/11, global warming, the collapse of the 
Soviet Union—the list goes on. Amidst these rivers 
of change, however, a pessimist might note that one 
thing has remained fairly constant: the number of blind 
people worldwide.
The prevalence of blindness, as for that of any disorder, 
crucially is determined by its deﬁ nition. WHO deﬁ nes 
blindness as presenting visual acuity (ie, the acuity 
without glasses at the time of testing) in the better 
eye of less than 3/60. Previously the WHO deﬁ nition 
cited the best-corrected visual acuity. The logic behind 
the change was to capture individuals who are blind or 
visually impaired because of uncorrected refractive error 
(ie, correctable with spectacles).
The Global Burden of Disease Study 2010 (GBD) 
aims to provide robust data about the spatiotemporal 
distribution of major human diseases, including visual 
impairment, by age and sex worldwide. In The Lancet 
Global Health, Rupert Bourne and colleagues,1 for 
the Vision Loss Expert Group of the GBD, report the 
distribution and temporal changes in prevalence of 
blindness and moderate to severe vision impairment 
from 1990 to 2010, worldwide. According to the current 
WHO deﬁ nition, their data from 21 regions showed that 
31·8 million people were blind in 1990, and in 2010, 
32·4 million were blind.1–3 Of these, in 1990, 68% (95% 
uncertainty interval 65–70) were blind from treatable 
causes, compared with 65% (61–68) in 2010. Leading 
causes of blindness worldwide did not change between 
1990 and 2010: cataract (39% and 33%, respectively), 
uncorrected refractive error (20% and 21%), and macular 
degeneration (5% and 7%).
But the pessimist would be wrong to believe that 
nothing had changed. The most common cause of 
blindness is cataracts, which is an age-related disease. 
Since 1990, the worldwide population and its median 
age have increased. Hence, changes in demographics 
pose challenges for reduction of the prevalence of 
blindness, as they do for other age-related disorders. The 
optimist points out that the global age-standardised 
prevalence of blindness for adults aged 50 years and 
older decreased from 3·0% (95% CI 2·7–3·4) worldwide 
in 1990 to 1·9% (1·7–2·2) in 2010.3 A reduction in 
the prevalence of blindness caused by infections, 
particularly trachoma and onchocerciasis, was seen, 
and was achieved mainly through improved infection 
control. The proportion of global blindness attributed 
to uncorrected refractive error did not change, and has 
remained at around 20% since 1990.
Of interest is that Bourne and colleagues used 
Bayesian hierarchical modelling to provide credible 
intervals for prevalence of vision impairment. A 
similar method was used to provide estimates for the 
proportion of blindness attributable to various causes. 
Researchers trained in frequentist statistics will not be 
familiar with this form of statistical analysis. Bayesian 
statistics are rarely seen in randomised clinical trials and 
are virtually unheard of in medical laboratory science. 
Although it has been argued that the Bayesian omelette 
cannot be made without breaking Bayesian eggs, a 
Bayesian approach lends itself to hierarchical models, 
and is arguably the manner in which clinical medicine 
and science is conducted in practice.
A substantial proportion of blindness due to un-
corrected refractive error is probably related to nuclear 
cataract, which defocuses as well as obscures vision. 
The misclassiﬁ cation in epidemiological studies occurs 
because the WHO protocol for blindness surveys 
instructs researchers to designate as the principal 
cause of vision impairment that which is most easily 
treatable. Hence, cataract-induced refractive error 
might be recorded as uncorrected refractive error when, 
in fact, the individual requires surgical intraocular-
lens implantation rather than glasses. Increased rates 
of cataract surgery earlier in the disease course (with 
accurate biometric assessment of intraocular-lens 
power) would reduce the prevalence of blindness due to 
cataract, uncorrected refractive error, and angle-closure 
glaucoma, which would kill three birds with one stone.4
A shocking discrepancy of up to 50 times diﬀ erence in 
the prevalence of blindness remains between developed 
countries and developing regions. In fact, population-
based studies from developed regions rarely report the 
prevalence based on the WHO deﬁ nition. Extrapolation 
from available data shows that 0·1–0·2% of adults aged 
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40 years and older in Australia and the USA are blind 
according to the WHO deﬁ nition,5,6 whereas in central 
Myanmar the rate is 8·0%.7
Heraclitus was right, of course, everything is in ﬂ ux. 
Rates of change diﬀ er and may be frustratingly slow, 
but those interested in reducing the burden of blindness 
should be encouraged by the trends reported by 
Bourne and colleagues.1 They should not, however, be 
complacent. Challenges remain and further reductions 
in the prevalence of blindness will not come easily as 
the rates of age-related retinal and optic-nerve diseases 
increase with the ageing population. Nevertheless, 
a scientiﬁ c approach to programme delivery in 
collaboration with local health workers will continue to 
reap rewards.8 
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